CASE COMMENTS : UNITED STATES – HEALTHCARE - PRIVATE ENFORCEMENT – FTAIA – DOMESTIC EFFECTS EXCEPTION – FOREIGN CARTEL

United States - Class actions: A District Court’s gives some indications concerning the extraterritorial application of the U.S. federal antitrust law in the Vitamin C Chinese cartel case (In re Vitamin C Antitrust Litigation)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. U.S. District Court E.D.N.Y., In re Vitamin C Antitrust Litigation The present case is a perfect illustration of the globalization of competition law (on this theme, see the work of CREDIMI, Mondialisation et droit de la concurrence, Litec 2008, and especially the concluding report by L. Idot). It highlights once again the complexity of the issues related to the application of U.S. law when the litigious conduct is mainly located abroad (In re Vitamin C Antitrust Litigation, F.Supp.2d, U.S. District Court, E.D.N.Y., No. 05-CV-0453, 06-MD-1738 BMC JO). This case involved a cartel, mainly composed of Chinese companies, affecting vitamin C shipped to the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Jean-Christophe Roda, United States - Class actions: A District Court’s gives some indications concerning the extraterritorial application of the U.S. federal antitrust law in the Vitamin C Chinese cartel case (In re Vitamin C Antitrust Litigation), 16 November 2012, Concurrences N° 1-2013, Art. N° 50796, pp. 222-224

Visites 251

All reviews